109 related articles for article (PubMed ID: 31597402)
21. Application of miRNAs in the diagnosis and monitoring of testicular germ cell tumours.
Almstrup K; Lobo J; Mørup N; Belge G; Rajpert-De Meyts E; Looijenga LHJ; Dieckmann KP
Nat Rev Urol; 2020 Apr; 17(4):201-213. PubMed ID: 32157202
[TBL] [Abstract][Full Text] [Related]
22. The Role of miRNA in Testicular Cancer: Current Insights and Future Perspectives.
Ditonno F; Franco A; Manfredi C; Fasanella D; Abate M; La Rocca R; Crocerossa F; Iossa V; Falagario UG; Cirillo L; Altieri VM; Di Mauro E; Crocetto F; Barone B; Cilio S; Pandolfo SD; Aveta A; Mirone V; Franzese CA; Arcaniolo D; Napolitano L
Medicina (Kaunas); 2023 Nov; 59(11):. PubMed ID: 38004082
[No Abstract] [Full Text] [Related]
23. Detection of Recurrence through microRNA-371a-3p Serum Levels in a Follow-up of Stage I Testicular Germ Cell Tumors in the DRKS-00019223 Study.
Belge G; Dumlupinar C; Nestler T; Klemke M; Törzsök P; Trenti E; Pichler R; Loidl W; Che Y; Hiester A; Matthies C; Pichler M; Paffenholz P; Kluth L; Wenzel M; Sommer J; Heinzelbecker J; Schriefer P; Winter A; Zengerling F; Kramer MW; Lengert M; Frey J; Heidenreich A; Wülfing C; Radtke A; Dieckmann KP
Clin Cancer Res; 2024 Jan; 30(2):404-412. PubMed ID: 37967143
[TBL] [Abstract][Full Text] [Related]
24. Dysregulated expression of miR‑367 in disease development and its prospects as a therapeutic target and diagnostic biomarker (Review).
Muniandy S; Few LL; Khoo BY; Hassan SA; Yvonne-Τee GB; See Too WC
Biomed Rep; 2023 Dec; 19(6):91. PubMed ID: 37901877
[TBL] [Abstract][Full Text] [Related]
25. Epigenetic Factors and ncRNAs in Testicular Cancer.
Nuñez-Corona D; Contreras-Sanzón E; Puente-Rivera J; Arreola R; Camacho-Nuez M; Cruz Santiago J; Estrella-Parra EA; Torres-Romero JC; López-Camarillo C; Alvarez-Sánchez ME
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569569
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-371a-3p-The Novel Serum Biomarker in Testicular Germ Cell Tumors.
Nestler T; Schoch J; Belge G; Dieckmann KP
Cancers (Basel); 2023 Aug; 15(15):. PubMed ID: 37568759
[TBL] [Abstract][Full Text] [Related]
27. [miR-367-3p Regulates Cells Proliferation and Invasion in NSCLC by Targeting ZEB2].
Su Y; Zhang H
Zhongguo Fei Ai Za Zhi; 2022 Nov; 25(11):782-788. PubMed ID: 36419391
[TBL] [Abstract][Full Text] [Related]
28. The Role of microRNAs in the Gonocyte Theory as Target of Malignancy: Looking for Potential Diagnostic Biomarkers.
García-Andrade F; Vigueras-Villaseñor RM; Chávez-Saldaña MD; Rojas-Castañeda JC; Bahena-Ocampo IU; Aréchaga-Ocampo E; Díaz-Chávez J; Landero-Huerta DA
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142439
[TBL] [Abstract][Full Text] [Related]
29. DigiMir Test: Establishing a Novel Pipeline for MiR-371a Quantification Using Droplet Digital PCR in Liquid Biopsies From Testicular Germ Cell Tumor Patients.
Sequeira JP; Lobo J; Constâncio V; Brito-Rocha T; Carvalho-Maia C; Braga I; Maurício J; Henrique R; Jerónimo C
Front Oncol; 2022; 12():876732. PubMed ID: 35756620
[TBL] [Abstract][Full Text] [Related]
30. Serum Levels of MicroRNA-371a-3p (M371) Can Predict Absence or Presence of Vital Disease in Residual Masses After Chemotherapy of Metastatic Seminoma.
Dieckmann KP; Klemke M; Grobelny F; Radtke A; Dralle-Filiz I; Wülfing C; Belge G
Front Oncol; 2022; 12():889624. PubMed ID: 35600346
[TBL] [Abstract][Full Text] [Related]
31. Epigenetics and Testicular Cancer: Bridging the Gap Between Fundamental Biology and Patient Care.
Nicu AT; Medar C; Chifiriuc MC; Gradisteanu Pircalabioru G; Burlibasa L
Front Cell Dev Biol; 2022; 10():861995. PubMed ID: 35465311
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic, Prognostic and Predictive Markers in Pediatric Germ Cell Tumors-Past, Present and Future.
Jezierska M; Gawrychowska A; Stefanowicz J
Diagnostics (Basel); 2022 Jan; 12(2):. PubMed ID: 35204369
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-profiling of miR-371~373- and miR-302/367-clusters in serum and cerebrospinal fluid identify patients with intracranial germ cell tumors.
Schönberger S; Mohseni MM; Ellinger J; Tran GVQ; Becker M; Claviez A; Classen CF; Hermes B; Driever PH; Jorch N; Lauten M; Mehlitz M; Schäfer N; Scheer-Preiss J; Schneider DT; Troeger A; Calaminus G; Dilloo D
J Cancer Res Clin Oncol; 2023 Feb; 149(2):791-802. PubMed ID: 35171328
[TBL] [Abstract][Full Text] [Related]
34. Narrative review of developing new biomarkers for decision making in advanced testis cancer.
Nappi L; Nichols C; Kollmannsberger C
Transl Androl Urol; 2021 Oct; 10(10):4075-4084. PubMed ID: 34804849
[TBL] [Abstract][Full Text] [Related]
35. Combining Hypermethylated
Lobo J; van Zogchel LMJ; Nuru MG; Gillis AJM; van der Schoot CE; Tytgat GAM; Looijenga LHJ
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680375
[TBL] [Abstract][Full Text] [Related]
36. Improving outcomes in germ cell cancers using miRNA.
Conduit C; Tran B
Ther Adv Med Oncol; 2021; 13():17588359211027826. PubMed ID: 34262617
[TBL] [Abstract][Full Text] [Related]
37. Liquid Biopsies in the Clinical Management of Germ Cell Tumor Patients: State-of-the-Art and Future Directions.
Lobo J; Leão R; Jerónimo C; Henrique R
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800799
[TBL] [Abstract][Full Text] [Related]
38. miRNAs and Biomarkers in Testicular Germ Cell Tumors: An Update.
De Martino M; Chieffi P; Esposito F
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573132
[TBL] [Abstract][Full Text] [Related]
39. Oxymatrine inhibits the development of non-small cell lung cancer through miR-367-3p upregulation and target gene
Yu Q; Luo J; Zhang J; Chen Y; Chen K; Lin J; Sun S; Lin X
Am J Transl Res; 2020; 12(9):5538-5550. PubMed ID: 33042436
[TBL] [Abstract][Full Text] [Related]
40. Graded expression of microRNA-371a-3p in tumor tissues, contralateral testes, and in serum of patients with testicular germ cell tumor.
Belge G; Hennig F; Dumlupinar C; Grobelny F; Junker K; Radtke A; Dieckmann KP
Oncotarget; 2020 Apr; 11(16):1462-1473. PubMed ID: 32363003
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
